High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$991K
$991,989
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$239,427
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $239,427 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$210,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $210,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$165,541
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $165,541 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$163,040
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $163,040 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$75,317
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $75,317 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$49,915
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $49,915 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$48,041
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $48,041 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$39,904
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $39,904 | S | Form 4 |